Expertise in
1
conditions

Shawgi Sukumaran

Bedford Park, 
Adelaide, SA, AU 
Expertise in
1
conditions
Bedford Park, 
Adelaide, SA, AU 

Overview

Shawgi Sukumaran practices practicing medicine in Adelaide, Australia.

Sukumaran is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Small Cell Lung Cancer (SCLC), Febrile Neutropenia, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).

They are actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 4 clinical trials.

Locations

Bedford Park, Adelaide, SA 5042, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
Enrollment Status: Completed
Publish Date: January 22, 2026
Intervention Type: Drug
Study Drug: Durvalumab
Study Phase: Phase 3
Phase III, Double-Blind, Placebo-Controlled Study of Post-Operative Adjuvant Concurrent Chemo-Radiotherapy With or Without Nimotuzumab for Stage III/IV Head & Neck Squamous Cell Cancer
Phase III, Double-Blind, Placebo-Controlled Study of Post-Operative Adjuvant Concurrent Chemo-Radiotherapy With or Without Nimotuzumab for Stage III/IV Head & Neck Squamous Cell Cancer
Enrollment Status: Unknown
Publish Date: January 09, 2024
Intervention Type: Drug
Study Drug: Nimotuzumab
Study Phase: Phase 3
A Phase 2 Trial of Durvalumab (MEDI4736) and Tremelimumab With Chemotherapy in Metastatic EGFR Mutant Non-squamous Non-small Cell Lung Cancer (NSCLC) Following Progression on EGFR Tyrosine Kinase Inhibitors (TKIs)
A Phase 2 Trial of Durvalumab (MEDI4736) and Tremelimumab With Chemotherapy in Metastatic EGFR Mutant Non-squamous Non-small Cell Lung Cancer (NSCLC) Following Progression on EGFR Tyrosine Kinase Inhibitors (TKIs)
Enrollment Status: Unknown
Publish Date: April 21, 2023
Intervention Type: Drug
Study Drugs: Tremelimumab, Durvalumab
Study Phase: Phase 2
TROG12.01 A Randomised Trial of Weekly Cetuximab and Radiation Versus Weekly Cisplatin and Radiation in Good Prognosis Locoregionally Advanced HPV-Associated Oropharyngeal Squamous Cell Carcinoma
TROG12.01 A Randomised Trial of Weekly Cetuximab and Radiation Versus Weekly Cisplatin and Radiation in Good Prognosis Locoregionally Advanced HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Enrollment Status: Unknown
Publish Date: November 18, 2022
Intervention Type: Drug, Radiation
Study Drugs: Cetuximab, Cisplatin
Study Phase: Phase 3
View 3 Less Clinical Trials

19 Total Publications

Radiation Recall Supraglottitis Triggered by Pembrolizumab in a Patient With Metastatic Non-small Cell Lung Cancer: A Case Report.
Radiation Recall Supraglottitis Triggered by Pembrolizumab in a Patient With Metastatic Non-small Cell Lung Cancer: A Case Report.
Journal: Cureus
Published: February 04, 2026

Frequently Asked Questions about Shawgi Sukumaran

Is Shawgi Sukumaran a top-rated expert for Small Cell Lung Cancer (SCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Shawgi Sukumaran is classified as an Advanced expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shawgi Sukumaran participate in research or clinical trials?

Yes. Shawgi Sukumaran has published 19 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Shawgi Sukumaran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sukumaran's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile